AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 81 filers reported holding AUDENTES THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $25,234,000 | +11.0% | 660,406 | -12.7% | 0.66% | +4.1% |
| Q1 2018 | $22,724,000 | -6.9% | 756,215 | -3.2% | 0.64% | -21.4% |
| Q4 2017 | $24,416,000 | -44.2% | 781,309 | -50.0% | 0.81% | -3.2% |
| Q3 2017 | $43,770,000 | +223.4% | 1,562,618 | +120.9% | 0.84% | +22.8% |
| Q2 2017 | $13,534,000 | +10473.4% | 707,500 | +9333.3% | 0.68% | +9628.6% |
| Q1 2017 | $128,000 | -6.6% | 7,500 | 0.0% | 0.01% | -30.0% |
| Q4 2016 | $137,000 | +2.2% | 7,500 | 0.0% | 0.01% | +11.1% |
| Q3 2016 | $134,000 | – | 7,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 1,204,615 | $37,644,219,000 | 39.61% |
| Casdin Capital, LLC | 400,000 | $12,500,000 | 3.04% |
| Opaleye Management Inc. | 210,000 | $6,652,000 | 2.13% |
| Orbimed Advisors | 4,129,638 | $129,051,000 | 1.63% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,190,516 | $37,204,000 | 1.46% |
| Redmile Group, LLC | 929,326 | $29,041,000 | 1.26% |
| Cormorant Asset Management, LP | 337,876 | $10,559,000 | 1.10% |
| Perceptive Advisors | 781,309 | $24,416,000 | 0.81% |
| Rock Springs Capital Management LP | 525,000 | $16,406,000 | 0.74% |
| Virtus ETF Advisers LLC | 11,898 | $372,000 | 0.47% |